Medha Kamat
Director, Oncology Biomarker & Diagnostic Operations Johnson & Johnson
Seminars
Monday 16th November 2026
Panel Discussion: Choosing Build vs. Buy for Sample Tracking Technology & Making Either Work at Scale
1:45 pm
- Weighing custom-built platforms against off-the-shelf LIMS and sample tracking software to match technology investment to trial complexity and organizational maturity
- Confronting Integration Reality: Connecting sample tracking systems with CTMS, LIMS, and central lab databases without creating new data silos
- Debating who owns technology decisions, translational science or clinical operations, and how that ownership shapes adoption and long-term scalability
